GlaxoSmithKline Biologicals S.A.;Glaxo Group Limited
发明人:
申请号：
EP09781058.4
公开号：
EP2315597B1
申请日:
2009.07.24
申请国别(地区):
EP
年份:
2017
代理人:
摘要：
The present invention is directed to a polypeptide which comprises: (i) an Rv1753c protein sequence； (ii) a variant of an Rv1753c protein sequence； or (iii) an immunogenic fragment of an Rv1753c protein sequence. In other aspects the invention is directed to associated polynucleotides, fusion proteins and methods for the treatment or prevention of tuberculosis.
